Your browser doesn't support javascript.
HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021.
Laher, Fatima; Richardson, Simone I; Smith, Philip; Sullivan, Patrick S; Abrahams, Andrea G; Asowata, Osaretin E; Bitangumutwenzi, Patrick; Dabee, Smritee; Dollah, Annabell; Fernandez, Natalia; Langat, Robert K; Bose, Devi Leena; Likhitwonnawut, Udom; Mullick, Ranajoy; Resop, Rachel S; Sutar, Jyoti; Thompson-Hall, Ashaki Nzingha; Traeger, Michael W; Tuyishime, Marina; Wambui, Jacque; Bekker, Linda-Gail; Kaleebu, Pontiano; McCormack, Sheena; O'Connor, David H; Warren, Mitchell; Torri, Tamara; Thyagarajan, Bargavi.
  • Laher F; University of the Witwatersrand, Johannesburg, South Africa.
  • Richardson SI; University of the Witwatersrand, Johannesburg, South Africa.
  • Smith P; National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Sullivan PS; The Desmond Tutu HIV Research Centre, Cape Town, South Africa.
  • Abrahams AG; Emory University, Atlanta, Georgia, USA.
  • Asowata OE; University of Cape Town, Cape Town, South Africa.
  • Bitangumutwenzi P; Africa Health Research Institute, Durban, South Africa.
  • Dabee S; Yowli Burundi, Bujumbura, Burundi.
  • Dollah A; Seattle Children's Research Institute, Seattle, Washington, USA.
  • Fernandez N; Kenya medical Research Institute, Nairobi, Kenya.
  • Langat RK; IAVI Human Immunology Laboratory, London, United Kingdom.
  • Bose DL; University of Nairobi, Nairobi, Kenya.
  • Likhitwonnawut U; International AIDS Vaccine Initiative (IAVI), New Delhi, India.
  • Mullick R; Vaccine Advocacy Resource Group, Bangkok, Thailand.
  • Resop RS; International AIDS Vaccine Initiative (IAVI), New Delhi, India.
  • Sutar J; The George Washington University, Washington, District of Columbia, USA.
  • Thompson-Hall AN; Indian Council of Medical Research (ICMR), Mumbai, India.
  • Traeger MW; SisterLove, Inc., Atlanta, United States.
  • Tuyishime M; Burnet Institute, Melbourne, Australia.
  • Wambui J; Duke University, Durham, North Carolina, USA.
  • Bekker LG; AFROCAB Treatment Access Partnerships, Nairobi, Kenya.
  • Kaleebu P; The Desmond Tutu HIV Research Centre, Cape Town, South Africa.
  • McCormack S; Uganda Virus Research Institute & MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • O'Connor DH; MRC Clinical Trials Unit, London, United Kingdom.
  • Warren M; University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Torri T; AVAC, New York, New York, USA.
  • Thyagarajan B; International AIDS Society, Geneva, Switzerland.
AIDS Res Hum Retroviruses ; 38(5): 350-358, 2022 05.
Article in English | MEDLINE | ID: covidwho-1486408
ABSTRACT
The HIV Research for Prevention (HIVR4P) conference catalyzes knowledge sharing on biomedical HIV prevention interventions such as HIV vaccines, antibody infusions, pre-exposure prophylaxis, and microbicides in totality-from the molecular details and delivery formulations to the behavioral, social, and structural underpinnings. HIVR4P // Virtual was held over the course of 2 weeks on January 27-28 and February 3-4, 2021 as the coronavirus disease 2019 (COVID-19) pandemic continued to inflict unprecedented harm globally. The HIVR4P community came together with 1,802 researchers, care providers, policymakers, implementers, and advocates from 92 countries whose expertise spanned the breadth of the HIV prevention pipeline from preclinical to implementation. The program included 113 oral and 266 poster presentations. This article presents a brief summary of the conference highlights. Complete abstracts, webcasts, and daily rapporteur summaries may be found on the conference website (https//www.hivr4p.org/).
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / AIDS Vaccines / Anti-HIV Agents / Pre-Exposure Prophylaxis / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Topics: Vaccines Limits: Humans Language: English Journal: AIDS Res Hum Retroviruses Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article Affiliation country: AID.2021.0138

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / AIDS Vaccines / Anti-HIV Agents / Pre-Exposure Prophylaxis / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Topics: Vaccines Limits: Humans Language: English Journal: AIDS Res Hum Retroviruses Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article Affiliation country: AID.2021.0138